Aigen Investment Management LP Acquires Shares of 37,737 Procter & Gamble Company (The) $PG

Key Points

• Aigen Investment Management opened a new position in Procter & Gamble, buying 37,737 shares valued at about $5.4 million, making PG its third-largest holding.
• Procter & Gamble reported Q4 earnings of $1.59 per share, topping estimates, while revenue came in at $21.24 billion, slightly below expectations but still up 7.4% year over year.
• The company also raised its quarterly dividend to $1.0885 per share, and analysts currently rate the stock a Moderate Buy with an average price target of $160.78.

Aigen Investment Management LP acquired a new stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 37,737 shares of the company's stock, valued at approximately $5,408,000. Procter & Gamble accounts for 1.3% of Aigen Investment Management LP's holdings, making the stock its 3rd biggest holding.

Several other large investors have also recently added to or reduced their stakes in PG. Atlas Capital Advisors Inc. bought a new stake in Procter & Gamble in the fourth quarter worth approximately $39,007,000. Arete Wealth Advisors LLC grew its position in Procter & Gamble by 9.8% in the fourth quarter. Arete Wealth Advisors LLC now owns 27,009 shares of the company's stock worth $3,871,000 after acquiring an additional 2,419 shares in the last quarter. Jacobi Capital Management LLC grew its position in Procter & Gamble by 2.4% in the fourth quarter. Jacobi Capital Management LLC now owns 39,616 shares of the company's stock worth $5,677,000 after acquiring an additional 942 shares in the last quarter. Nan Shan Life Insurance Co. Ltd. grew its position in Procter & Gamble by 2.6% in the fourth quarter. Nan Shan Life Insurance Co. Ltd. now owns 276,626 shares of the company's stock worth $39,643,000 after acquiring an additional 7,000 shares in the last quarter. Finally, Burton Enright Welch bought a new stake in Procter & Gamble in the fourth quarter worth approximately $440,000. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock opened at $149.47 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The firm has a fifty day moving average price of $144.63 and a two-hundred day moving average price of $147.70. The company has a market cap of $348.04 billion, a PE ratio of 21.85, a price-to-earnings-growth ratio of 6.51 and a beta of 0.39.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, beating analysts' consensus estimates of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The firm had revenue of $21.24 billion during the quarter, compared to the consensus estimate of $21.52 billion. During the same period in the prior year, the firm earned $1.54 EPS. The business's revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were issued a $1.0885 dividend. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date of this dividend was Friday, April 24th. This represents a $4.35 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble's payout ratio is currently 63.60%.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Sanford C. Bernstein assumed coverage on shares of Procter & Gamble in a research report on Thursday. They issued a "market perform" rating and a $156.00 target price for the company. Wells Fargo & Company boosted their target price on shares of Procter & Gamble from $158.00 to $164.00 and gave the stock an "overweight" rating in a research report on Monday, April 27th. JPMorgan Chase & Co. decreased their target price on shares of Procter & Gamble from $165.00 to $162.00 and set an "overweight" rating for the company in a research report on Friday, April 17th. Bank of America decreased their target price on shares of Procter & Gamble from $171.00 to $167.00 and set a "buy" rating for the company in a research report on Friday, April 10th. Finally, Jefferies Financial Group decreased their target price on shares of Procter & Gamble from $179.00 to $175.00 and set a "buy" rating for the company in a research report on Monday, April 20th. Eleven analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. Based on data from MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and an average price target of $160.78.

About Procter & Gamble

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.